Increased cell-mediated immune responses in patients with recurrent herpes simplex virus type 2 meningitis.
Franzen-Röhl E, Schepis D, Lagrelius M, Franck K, Jones P, Liljeqvist JÅ, Bergström T, Aurelius E, Kärre K, Berg L, et al. Clin Vaccine Immunol. 2011 Apr; 18(4):655-60. Epub 2011 Feb 16.